Wasn’t mine 🙂
As part of the controversy series in multiple sclerosis journal Dr. Aaron Miller, New York picked his favourite 2012 papers based on papers that “will have the greatest impact on clinical understanding or management of MS”. He picked the brace of papers on BG-12 including Placebo-controlled phase 3 study of oral BG-12 for relapsing multiple sclerosis by Ralph Gold, Prof G and others and that of Bob Fox and co. Michael Hitchins from Dublin however picked Doug Goodlin and 21 years of beta interferon follow-up.
Personally, I can’t be bothered with such Professional back-slapping (jealous) but well done to the Authors. All well deserved.
What’s your favourite?
Just as you have the “Razzies” to counter the “Oscars” wonder if they will do the Turkey paper of 2012…maybe too many to choose from:-)